Philipsen wins Tour stage 17 as UCI defends late-night tests

Philipsen takes stage 17

Belgium's Jasper Philipsen claimed stage 17 of the Tour de France, adding another major result to a race already deep into its final phase. A stage win at this point of the Tour matters because opportunities are running out, and every remaining day is shaped by fatigue, team priorities, and the pressure of a race nearing its conclusion.

The headline is not only the sporting result. It also places Philipsen's win alongside a governance issue that sits close to the centre of elite racing: the UCI defending its controversial late-night drug testing.

Why it matters

For riders and teams, anti-doping procedures are part of the operating environment of the Tour, but timing matters. When testing is described as late-night and controversial, the question is not whether controls are important, but how they are implemented around the demands of racing and recovery.

That combination makes this more than a routine stage report. Philipsen gets the stage, while the UCI's position keeps the broader discussion around testing protocols in view.

Full details are at the linked ABC News source.